Preclinical Evaluation of 9MW2821, a Site-Specific Monomethyl Auristatin E–based Antibody–Drug Conjugate for Treatment of Nectin-4–expressing Cancers
Wei Zhou(National Institutes of Pharmaceutical Research and Development (China)), Jingkang Shen(Shanghai Institute of Materia Medica)
Cited by 41
Related Papers
Enzymatic activity characterization of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer technique1
|Acta Pharmacologica Sinica|2005|58
Knockdown of YAP/TAZ Inhibits the Migration and Invasion of Fibroblast Synovial Cells in Rheumatoid Arthritis by Regulating Autophagy
|Journal of Immunology Research|2020|39
Illudalic acid as a potential LAR inhibitor: Synthesis, SAR, and preliminary studies on the mechanism of action
|Bioorganic & Medicinal Chemistry|2008|28